Wird geladen...
Regulatory post‐market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies
Information on rare adverse effects is often limited when a medication is initially approved for marketing. Medicines regulators use safety advisories to warn health professionals and consumers about emerging harms. This study aimed to identify characteristics and advice provided in cardiac safety a...
Gespeichert in:
| Veröffentlicht in: | Pharmacol Res Perspect |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7652786/ https://ncbi.nlm.nih.gov/pubmed/33169534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/prp2.680 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|